Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

Dr Reddys Laboratories Australia Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

Cancellation by sponsor (326)
ARTG (261)
Prescription medicine registration (29)
Prescription medicine evaluation (3)
Designation or determination (2)

Date

2026 (47)
2025 (31)
2024 (51)
2023 (161)
2022 (30)
2021 (31)
2020 (45)
2019 (26)
2018 (50)
2017 (35)
2016 (77)
2015 (2)
2014 (1)
2013 (5)
2012 (10)
2011 (2)
2010 (10)
2008 (2)
2002 (2)
2001 (3)

Search

Sponsor content

621 result(s) found, displaying 81 to 90

Notice for Olutasidenib (Dr Reddys Laboratories Australia Pty Ltd)

28 May 2025

Designation or determination

Orphan drug
APIXABAN DR.REDDY'S (Dr Reddys Laboratories Australia Pty Ltd)

28 April 2025

Prescription medicine registration

Active ingredients: apixaban.
LINAGLIPTIN DR.REDDY'S (Dr Reddys Laboratories Australia Pty Ltd)

21 March 2025

Prescription medicine registration

Active ingredients: linagliptin.
NILOTINIB (Dr Reddys Laboratories Australia Pty Ltd)

21 March 2025

Prescription medicine registration

Active ingredients: Nilotinib hydrochloride monohydrate.
PAZOPANIB DR. (Dr Reddys Laboratories Australia Pty Ltd)

19 March 2025

Prescription medicine registration

Active ingredients: pazopanib hydrochloride.
ISOTRETINOIN DR REDDY'S (Dr Reddys Laboratories Australia Pty Ltd)

7 March 2025

Prescription medicine registration

Active ingredients: isotretinoin.
ABIRATERONE DR.REDDY'S (Dr Reddys Laboratories Australia Pty Ltd)

18 February 2025

Prescription medicine registration

Active ingredients: abiraterone acetate.
MIDOSTAURIN (Dr Reddys Laboratories Australia Pty Ltd)

4 February 2025

Prescription medicine registration

Active ingredients: midostaurin.
PIRFENIDONE DR REDDY'S pirfenidone 267 mg film-coated tablet bottle (407541)

2 February 2024

ARTG

Australian Register of Therapeutic Goods (ARTG) information for PIRFENIDONE DR REDDY'S pirfenidone 267 mg film-coated tablet bottle.
PIRFENIDONE DR REDDY'S pirfenidone 801 mg film-coated tablet bottle (407540)

2 February 2024

ARTG

Australian Register of Therapeutic Goods (ARTG) information for PIRFENIDONE DR REDDY'S pirfenidone 801 mg film-coated tablet bottle.

Pages

First page
Previous page
…
Page 5
Page 6
Page 7
Page 8
Current page 9
Page 10
Page 11
Page 12
Page 13
…
Next page
Last page

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.